Claims for Patent: 6,896,886

✉ Email this page to a colleague

Summary for Patent: 6,896,886

Title:	Use of botulinum toxins for treating various disorders and conditions and associated pain
Abstract:	A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G.
Inventor(s):	Aoki; K. Roger (Laguna Hills, CA), Grayston; Michael W. (Irvine, CA), Carlson; Steven R. (Laguna Niguel, CA), Leon; Judith M. (Laguna Niguel, CA)
Assignee:	Allergan, Inc. (Irvine, CA)
Application Number:	09/906,496
Patent Claims:	1. A method for the control of autonomic nerve function in a mammal comprising locally administering to cholinergic neurons of the autonomic system of the mammal an amount of botulinum toxin sufficient to cause denervation of the neurons, wherein said denervation results in control of autonomic nerve function in a target tissue or organ innervated by said neurons, wherein the autonomic nerve function includes the function of an autonomic nerve which contributes to at least one symptom of excessive sweating. 2. A method according to claim 1 for alleviating excessive sweating, comprising administering a therapeutically effective amount of botulinum toxin to the skin of a human. 3. A method according to claim 2, wherein the botulinum toxin is administered by intradermal injection. 4. A method according to claim 1, wherein the botulinum toxin is at least one of botulinum toxins A, B, C, D, E, F or G. 5. A method according to claim 4, wherein the botulinum toxin is botulinum toxin A. 6. A method according to claim 4, wherein the botulinum toxin is botulinum toxin D.

Details for Patent 6,896,886

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Abbvie Inc.	BOTOX COSMETIC	onabotulinumtoxina	For Injection	103000	December 09, 1991	⤷ Sign Up	2013-12-28
Abbvie Inc.	BOTOX	onabotulinumtoxina	For Injection	103000	December 09, 1991	⤷ Sign Up	2013-12-28
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 6,896,886

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration
Australia	1516295	⤷ Sign Up
Australia	688452	⤷ Sign Up
Australia	7010598	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.